GlaxoSmithKline logo

Clinical R&D

Worldwide development
Every drug we develop undergoes a series of safety and efficacy tests, registration with regulatory authorities and monitoring of its use. At the centre of all this is our Worldwide Development function.

Scientists and physicians design and execute highly regulated clinical trials that involve hundreds or even thousands of patients, and can take over three years to complete. The data is then collected, analysed and summarized in the preparation of regulatory dossiers needed to gain approval for use around the world.

This process involves substantial financial resources as well as broad expertise, not only in science and medicine, but also in business and drug regulation. By partnering with healthcare professionals, we're able transform these rigorous and exacting responsibilities into efficient, well-orchestrated programs, ensuring we deliver the medicines that patients need.



Back to top
Research and development
Research & development
Find out more

About R&D at GSK

Image of disability symbol
Accessibility and disability